Novel magnesium alloy Mg-2La caused no cytotoxic effects on cells in physiological conditions.

Using several different in vitro assays, a new biodegradable magnesium alloy Mg-2La, composed of 98% magnesium and 2% lanthanum, was investigated as a possible implant material for biomedical applications. An in vitro cytotoxicity test, according to EN ISO 10993-5/12, with L929 and human osteoblastic cells identified no toxic effects on cell viability at physiological concentrations (at 50% dilutions and higher). The metabolic activity of human osteoblasts in the 100% extract was decreased to <70% and was therefore rated as cytotoxic. The degradation rates of Mg-2La were evaluated in phosphate buffered saline and four different cell culture media. The degradation rates were shown to be influenced by the composition of the solution, and the addition of fetal bovine serum slightly accelerated the corrosive process. The results of these in vitro experiments suggest that Mg-2La is a promising candidate for use as an orthopedic implant material.

[1]  C. Vidaud,et al.  Bone as target organ for metals: the case of f-elements. , 2012, Chemical research in toxicology.

[2]  Csaba Vermes,et al.  Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblasts. , 2002, Journal of biomedical materials research.

[3]  M. S. Yong,et al.  In vitro degradation behavior of M1A magnesium alloy in protein-containing simulated body fluid , 2011 .

[4]  Andrej Atrens,et al.  Corrosion of high purity Mg, AZ91, ZE41 and Mg2Zn0.2Mn in Hank’s solution at room temperature , 2011 .

[5]  R. Willumeit,et al.  Ion release from magnesium materials in physiological solutions under different oxygen tensions , 2011, Journal of Materials Science: Materials in Medicine.

[6]  H. Haferkamp,et al.  In vivo corrosion of four magnesium alloys and the associated bone response. , 2005, Biomaterials.

[7]  Janine Fischer,et al.  Chemical surface alteration of biodegradable magnesium exposed to corrosion media. , 2011, Acta biomaterialia.

[8]  T. Woodfield,et al.  In-vitro dissolution of magnesium-calcium binary alloys: clarifying the unique role of calcium additions in bioresorbable magnesium implant alloys. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  P. Allain,et al.  Concentrations of rare earth elements in plasma and urine of healthy subjects determined by inductively coupled plasma mass spectrometry. , 1990, Clinical chemistry.

[10]  P. Chu,et al.  In vitro studies of biomedical magnesium alloys in a simulated physiological environment: a review. , 2011, Acta biomaterialia.

[11]  Frank Feyerabend,et al.  Magnesium degradation as determined by artificial neural networks. , 2013, Acta biomaterialia.

[12]  Frank Witte,et al.  Degradable biomaterials based on magnesium corrosion , 2008 .

[13]  Berend Denkena,et al.  Biodegradable magnesium implants for orthopedic applications , 2012, Journal of Materials Science.

[14]  Alexis M Pietak,et al.  Magnesium and its alloys as orthopedic biomaterials: a review. , 2006, Biomaterials.

[15]  Tim Woodfield,et al.  Magnesium alloys: predicting in vivo corrosion with in vitro immersion testing. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[16]  D. Kristoffersen,et al.  Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media. , 1992, European journal of radiology.

[17]  W. Rambeck,et al.  Study on the performance enhancing effect of rare earth elements in growing and fattening pigs. , 2001, Journal of animal physiology and animal nutrition.

[18]  D. M. Robinson,et al.  Lanthanum Carbonate , 2009, Drugs.

[19]  Karl Ulrich Kainer,et al.  Element distribution in the corrosion layer and cytotoxicity of alloy Mg-10Dy during in vitro biodegradation. , 2013, Acta biomaterialia.

[20]  S. Hirano,et al.  Exposure, metabolism, and toxicity of rare earths and related compounds. , 1996, Environmental health perspectives.

[21]  Frank Witte,et al.  Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines. , 2010, Acta biomaterialia.

[22]  M. Leeflang,et al.  In vitro degradation behavior and cytocompatibility of Mg–Zn–Zr alloys , 2010, Journal of materials science. Materials in medicine.

[23]  Y Akagawa,et al.  Action of FGMgCO3Ap-collagen composite in promoting bone formation. , 2003, Biomaterials.

[24]  P. Chu,et al.  Degradation behaviour of pure magnesium in simulated body fluids with different concentrations of HCO3 , 2011 .

[25]  J. Nellesen,et al.  In vitro and in vivo evaluation of biodegradable, open-porous scaffolds made of sintered magnesium W4 short fibres. , 2013, Acta biomaterialia.

[26]  P. Uggowitzer,et al.  Magnesium alloys for temporary implants in osteosynthesis: in vivo studies of their degradation and interaction with bone. , 2012, Acta biomaterialia.

[27]  Daniel Perchy,et al.  In vitro evaluation of the surface effects on magnesium-yttrium alloy degradation and mesenchymal stem cell adhesion. , 2012, Journal of biomedical materials research. Part A.

[28]  Kathleen K. Kaysinger,et al.  Extracellular pH modulates the activity of cultured human osteoblasts , 1998, Journal of cellular biochemistry.

[29]  Akiko Yamamoto,et al.  Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro , 2009 .

[30]  Yufeng Zheng,et al.  Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg–Ca, AZ31, AZ91 alloys , 2009, Biomedical materials.

[31]  S. Virtanen,et al.  Time-dependent electrochemical characterization of the corrosion of a magnesium rare-earth alloy in simulated body fluids. , 2008, Journal of biomedical materials research. Part A.

[32]  J. Sankar,et al.  Effect of biologically relevant ions on the corrosion products formed on alloy AZ31B: an improved understanding of magnesium corrosion. , 2013, Acta biomaterialia.

[33]  G. Song,et al.  Corrosion mechanisms of magnesium alloys , 1999 .